Register for free
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ventas, Inc. Common Stock (NY:VTR)

67.34 -0.73 (-1.07%)
Official Closing Price Updated: 7:00 PM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ventas, Inc. Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Ventas Announces Tax Treatment Of 2022 Distributions
From Ventas Inc.
Via Business Wire
Ventas Inc. REIT: Relief Rally Gains New Strength
While quite a few real estate investment trusts (REITs) are just now coming off of new lows, Ventas Inc. (NYSE: VTR) is up to a three-month high.  
Via Benzinga
3 Unloved REIT Sectors That Are On Fire
More than 200 publicly traded real estate investment trusts (REITs) across 13 sectors are traded on the stock market, according to the National Association of Real Estate Investment Trusts (Nareit)... 
Via Benzinga
The Latest Analyst Ratings for Ventas
 
Via Benzinga
5 Must-Buy REITs for Your January Buy List
Here are five exceptional REITs to buy that happen to offer consistent growth and healthy passive income for long-term investors right now. 
Via InvestorPlace
8 Analysts Have This to Say About Ventas
 
Via Benzinga
Expert Ratings for Ventas
Analysts have provided the following ratings for Ventas (NYSE:VTR) within the last quarter: 
Via Benzinga
7 Analysts Have This to Say About Ventas
Within the last quarter, Ventas (NYSE:VTR) has observed the following analyst ratings: 
Via Benzinga
Cadence and Ardent Health Services Launch Remote Care Management Program to Improve Care and Outcomes for Patients Outside of Clinics
From Cadence
Via Business Wire
2 High-Yield Dividend Stocks to Buy Before the End of 2022
These two stocks are positioned for growth in 2023. 
Via The Motley Fool
These 2 High-Yield Healthcare REITs Are Holding Up Better Than The Overall Market In 2022
Real estate investment trusts (REITs) operating in the healthcare sector, tend to have a trailing 10-year return of 11.6%, according to SP Global. 
Via Benzinga
Ventas Declares Fourth Quarter 2022 Dividend of $0.45 per Common Share
From Ventas, Inc.
Via Business Wire
This High-Yield Dividend Stock May Finally Be Ready to Start Growing Again
Ventas was hit hard during the early days of the coronavirus pandemic, but it is on the cusp of a recovery. 
Via The Motley Fool
Ventas Recognized for Industry ESG Leadership in 2022
From Ventas, Inc.
Via Business Wire
Ventas to Participate in Investor Meetings at Nareit’s REITworld 2022 Annual Conference
From Ventas, Inc.
Via Business Wire
Ventas Reports 2022 Third Quarter Results
From Ventas, Inc.
Via Business Wire
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
Ventas Announces Third Quarter 2022 Earnings Release Date and Conference Call
From Ventas, Inc.
Via Business Wire
From A to Z: All The REITs Hitting New 52-Week Lows This Week
From A to Z: All The REITs Hitting New 52-Week Lows This Week Real estate investment trusts (REITs) — and there are a lot of them — have gone from a New York Stock Exchange favorite to a stock to steer... 
Via Benzinga
Jim Cramer Says Stay Away From This Cybersecurity Company; He's Been 'Against Them The Whole Way Down'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said BlackBerry Limited (NYSE: BB) is losing money and he's been "against them the whole way down." 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  During Monday's trading, 528 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
Upgrades 
Via Benzinga
This Analyst Boosts Price Target On Satsuma Pharmaceuticals By 200%? Plus UBS Predicts $38 For General Motors
SVB Leerink raised the price target on Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) from $5 to $15. SVB Leerink analyst Marc Goodman upgraded the stock from Market Perform to Outperform. Satsuma... 
Via Benzinga
Tilray Brands To Rally Over 45%? Here Are 5 Other Price Target Changes For Monday
Cantor Fitzgerald raised Tilray Brands, Inc. (NASDAQ: TLRY) price target from $4.15 to $4.5. Cantor Fitzgerald analyst Pablo Zuanic maintained a Neutral rating on the stock. Tilray Brands shares fell... 
Via Benzinga
7 Undervalued REITs to Buy With Serious Profit Potential
In investing circles, undervalued REITs are among the most sought-after asset classes, but these ones possess added advantages. 
Via InvestorPlace
Ventas to Participate in Investor Meetings at Mizuho Healthcare REIT Conference 2022
From Ventas, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 456 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  Monday saw 825 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 1076 companies hit new 52-week lows. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS